The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to create new mRNA vaccines. Experts say this could potentially impact mRNA ...

As drug developers face mounting pressure to accelerate discovery timelines without sacrificing quality, QLNS-CHO offers a compelling solution.

Extend transfection complex formation time by up to 3 hours, reduce complex volume by >50% and maintain high titers and full ...

A team of Toronto researchers has received Health Canada approval to conduct clinical trials for a novel class of ...

Researchers at Harvard Medical School and Brigham and Women's Hospital designed an ingestible capsule that delivers liquid mRNA to the intestines, producing gene expression and reducing inflammation ...

You might be familiar with the terms "seggs" and "unalive" if you've spent time on social media platforms. They're a part of ...

Amsbio has introduced GenePORTER® Gold, a high-efficiency, lipid-based transfection reagent designed to deliver consistent ...